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Abstract We present a new approach that allows the identi¢-
cation of intron-split peptides from mass spectrometric data in
genomic databases. Our algorithm uses small regions of peptide
sequence information which are automatically deduced from de
novo amino acid sequence predictions together with the molec-
ular mass information of the precursor ion. The sequence pre-
dictions are based on selected collision-induced mass spectro-
metric fragmentation spectra. Fragments of the predicted
amino acid sequence are aligned with each of the six frames
of the translated genome and the precursor mass information
is used to assemble the corresponding tryptic peptides using the
sequence as a matrix. Hereby, intron-split peptides can be gath-
ered and in turn veri¢ed by mass spectrometric data interpreta-
tion tools such as Sequest.
# 2004 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
With the increasing number of sequenced genomes, the
need for new computational approaches is evident. Software
tools are needed to cover a broad range of applications. One
of the biggest obstacles is the correct identi¢cation of intron^
exon borders. To identify peptides and proteins from mass
spectrometric data several strategies have been developed
[1^6]. Up to now, none of these approaches has been able
to detect peptides which are split by introns when deduced
from genomic DNA sequences. Prediction of intron^exon
boundaries for the identi¢cation of open reading frames using
genomic data is performed by numerous software tools [7^15].
However, those predictions are often erroneous [15^18]. This
has especially been outlined in a recent study [19]. An exper-
imental veri¢cation of the Caenorhabditis elegans genome an-
notation demonstrated that 50% of the predicted genes (about
4000 genes) needed corrections in their intron^exon structures.
Recently, we analyzed light-harvesting proteins from Chla-
mydomonas reinhardtii in a detailed proteomic study [20].
There we realized that Sequest searches with mass spectromet-
ric data identi¢ed several peptides in EST databases which
could not be detected in the genomic database from C. rein-
hardtii. One possible explanation for this ¢nding is that these
peptides are split by introns when deduced from the genomic
sequence. It has been estimated that at least 20^25% [21] of
tryptic peptides deduced from genomic databases are split by
introns. Our new approach enables identi¢cation of these pep-
tides in conjunction with mass spectrometric data interpreta-
tion tools such as Sequest and thereby de¢nes intron^exon
borders. This approach is related to the sequence tag search
algorithm [1,4,22] and uses fragments of amino acid sequences
generated by de novo amino acid sequence predictions of
tandem mass spectrometry (MS/MS) data together with the
corresponding peptide mass of the respective precursor ion.
We named this newly developed algorithm the GenomicPep-
tideFinder (GPF).
2. Materials and methods
2.1. GPF data input
Queries for GPF were generated using de novo amino acid sequenc-
ing software (DeNovoX, Thermo Finnigan). Results produced by
DeNovoX with a relative probability equal to or greater than 0.1
were queried by GPF. Queries can include monoisotopic or average
masses and an identi¢cation string for the peptide:
Query e:g:½RZAAYPG½VVCFNPYNLGK
Z represents a cysteine that is carbamidomethylated (plus 57 Da).
2.2. Computer equipment
GPF was originally programmed in Java1 and was tested on sev-
eral platforms:
1. Pentium II, 400 MHz, 256 MB RAM, Windows 98
2. Pentium III, 966 MHz, 256 MB RAM, Windows XP
(Laptop)
3. Pentium IV, 2400 MHz, 1024 MB RAM, Windows 2000
4. IBM RS/6000, F80 4-Way RS64 III 450 MHz Proc, UNIX
2.3. GPF functions and settings
Each amino acid sequence prediction is computationally frag-
mented (all possible sequence stretches of a given size are produced)
and the resulting fragments are used to search for identities in the six
frame translation of the genomic database. Two searches are per-
formed: the ¢rst one with a longer stretch of amino acids to cut
down on processing time and the second one with a shorter sequence
which is only invoked if the ¢rst one results in matches in one of the
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genomic sca¡olds. The more stringently the ¢rst comparison is set (a
setting of ¢ve matching amino acids was used in this study), the faster
the search. For the second search, the number of matching amino
acids was lowered to three (in this study). In case an amino acid
sequence matches the translated genomic sequence (v 5 amino acids),
the adjacent tryptic cleavage sites are predicted and the respective
mass of the deduced tryptic peptide is determined. Then, four di¡erent
processes are activated that are aimed to identify peptides in a ge-
nomic database which match the search criteria. Selected peptides are
stored in a database (result database). When the respective precursor
mass matches the tryptic peptide’s mass, it is extracted and stored in
the result database (Process 1, Fig. 1). When process 1 does not result
in matching peptides, process 2 is activated which leads to excision of
a sequence between two independent amino acid sequence hits in a
single sca¡old (Process 2, Fig. 1). The respective tryptic peptide is
deduced from the genomic data and its mass is matched with that
of the precursor ion. In case the masses match within a speci¢ed error
range, the respective peptide is extracted and stored. When the mass
of the tryptic peptide that harbors the two assembled sequence frag-
ments does not agree with the mass of the precursor ion, the sequence
is extended from the end of the sequence fragments that hit the trans-
lation of the genomic sequence along the corresponding reading
frames using the deduced amino acid sequence as a matrix until the
resulting tryptic peptide matches the mass of the precursor ion (Pro-
cess 3, Fig. 1). Process 4 (Fig. 1) operates like process 2 but allows
sequence errors in the genomic database. Processes 2^4 lead to the
identi¢cation of putative tryptic peptides that are split by an intron
when deduced from the genomic sequence. For peptide sequences
which were found by GPF and were stored in the result database
an E value and a score were assigned (see below). An additional
validation step represents the correlation between the mass spectra
from which the de novo predictions and therefore the queries for
GPF were originally derived and peptides found by GPF using an
MS/MS search tool such as Sequest. These evaluation steps enable
GPF to identify peptides which are intron-split within the genomic
sequence.
For mass calculations monoisotopic masses were used. The error
window for mass deviations between a measured mass and the mass
of a deduced tryptic peptide was set at 700 ppm since this is the
approximate error window of the ion trap mass spectrometer. A
Java1 version of the GPF software with graphical user interface
can be obtained for basic research purposes upon request.
2.4. Mass spectrometry and sample preparation
LC-MS/MS analyses were performed with an LCQ Deca XP ion
trap mass spectrometer (Thermo Finnigan), which was coupled to a
nano-HPLC (Ultimate, LC-Packings), as described [20]. In case the
charge state of an ion could not be determined, both doubly and
triply charged ion states were taken into account for the de novo
amino acid sequence predictions.
Isolation of photosystem I particles and analyses by two-dimen-
sional gel electrophoresis were performed as described in [20].
2.5. De novo predictions
DeNovoX1 (Thermo Finnigan) was used to interpret mass spectra
which could not be identi¢ed by Sequest. The software provides two
markers for prediction quality. One is the absolute probability which
is only subject to the assumption that the chemical species being
sequenced is a peptide. The other, the relative probability, further
assumes that all necessary sequencing information is included in the
spectrum. According to the DeNovoX1 manual an absolute proba-
bility of 20% or more combined with a relative probability of 75% or
more is a strong indication that the sequence or subsequence is cor-
rect.
We only examined full length sequence predictions with a relative
probability equal to or greater than 10%.
2.6. Using GPF to connect de novo predictions to the original spectra
The GPF software de¢nes a database of possible peptides from de
novo predictions. This peptide list has to be checked against the orig-
inal spectrum to actually identify the correct peptide. This is done by
a correlation of the original spectrum with the in silico produced
spectra based on this database by Sequest or Mascot. GPF, therefore,
provides the link between de novo predictions and Sequest or Mascot
evaluation of MS/MS data.
2.7. E value and score calculation
An expectation value (E value) and a score were calculated. These
two values are used as parameters to cut the overall workload. If
peptides are clearly insigni¢cant (E value) or if they do not resemble
the de novo prediction (score) they are not further processed and thus
not stored. Threshold values can be set to exclude results. In our case
all results were stored which is also the default setting.
The E value re£ects the expectation for a peptide to occur randomly
within the genome. It is therefore dependent on the size of the ge-
Fig. 1. Abstract and simpli¢ed £ow chart of the work £ow of the GPF. Possible candidates are stored in a result database for further valida-
tion.
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nome, the sequence and the mass. The sequence in turn depends on
the local amino acid distribution as does the mass. A genome size of
100 Mb was used for E value calculations which corresponds to the
size of the C. reinhardtii genome (assembly 1) that was downloaded
from the Chlamydomonas Genetics Center (http://www.biology.du-
ke.edu/chlamy/). A probability below 0.05 is usually considered sig-
ni¢cant but for readability reasons 310 log10 (probability) was calcu-
lated so that E values above 106 can be considered signi¢cant [23]. To
assess the similarity between queries and their corresponding results
we introduced a scoring system. The score value would be 1 for a
perfect match and decreases with lower identity. The peptides listed in
Table 1 meet this signi¢cance criterion.
Since the E value and score calculations are merely used to set
limiting values we will not present the algorithms deployed here.
The exact formulas and their descriptions can be obtained upon re-
quest.
3. Results and discussion
To identify peptides in genomic databases, GPF starts with
an alignment of an amino acid sequence that originates from
an interpretation of a MS/MS spectrum using a DeNovoX
amino acid sequencing software with a respective genomic
database (Fig. 2). Such de novo amino acid sequence predic-
tions often result in more than one peptide sequence per
MS/MS spectrum. For GPF analysis we restricted the search
to those de novo peptide sequence predictions that were given
a relative probability equal to or higher than 0.1 (Table 1) as
de¢ned by the DeNovoX software.
As proof of principle, three examples are discussed in detail.
The functionality of process 1 is illustrated by GPF analyses
of de novo sequence predictions evaluated from an MS/MS
spectrum that also led to the identi¢cation of a peptide by
searching the Chlamydomonas EST and genomic databases
using Sequest [20]. The identi¢ed peptide WLQYSEVIHAR
is derived from the lhca3 gene product and is not split by an
intron in the nuclear lhca3 gene present in sca¡old 1152 of the
genomic database. Three de novo amino acid predictions of
that MS/MS spectrum (Table 1; A) were queried by GPF.
GPF found the peptide WLQYSEVIHAR two times in scaf-
fold 1152 which is due to several similar de novo prediction
alternatives. The E value together with score calculations by
GPF for this peptide indicate that this peptide is the most
signi¢cant tryptic peptide sequence among the sequences
found by GPF when analyzing the respective sequence
queries. The next two examples derive from MS/MS spectra
that did not result in signi¢cant Sequest scores using the ge-
nomic database but matched when searching the EST Chla-
mydomonas database. Evaluation of the MS/MS spectra
shown in Fig. 2B,C by DeNovoX resulted in the prediction
of several amino acid sequences that were used as queries for
GPF. These queries resulted in numerous tryptic peptide se-
quences which were found to be signi¢cant and good candi-
dates for further evaluation and were therefore collected by
GPF. Among these sequences peptide NFGSVNEDPIFK as
well as peptide GSGDAAYPGGPFFNLFNLGK resulted in
E values in conjunction with scores derived for the queries
deduced from MS/MS spectra 1B and 1C, respectively (Table
1), that were very promising. Analysis of the respective
MS/MS spectra using the Sequest algorithm and a database
that contains the peptides found by GPF can be used to prove
that the given peptides are represented by the MS/MS spectra
from which the de novo amino acid predictions were ob-
tained. This analysis resulted in cross-correlation factorsT
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(XCorr) well above 2.5 for the peptides NFGSVNEDPIFK and
GSGDAAYPGGPFFNLFNLGK. An XCorr value larger than
2.5 is considered to be signi¢cant for fragmentation spectra of
doubly charged precursor ions [6] (Table 1). The Sequest
search therefore con¢rmed the GPF predictions. For peptide
NFGSVNEDPIFK GPF predicts the following intron^exon
boundary: NFGSVNE-intron-DPIFK. This peptide can be
deduced from the lhca5 gene product [20] and is split by an
intron in the nuclear gene exactly as predicted by GPF. In this
case the amino acid sequence predicted by DeNovoX allowed
GPF to determine the correct intron^exon boundary (Fig. 1,
Process 2). For peptide GSGDAAYPGGPFFNLFNLGK
Fig. 2. MS/MS spectra of doubly charged precursor ions and the resulting de novo amino acid sequence predictions. (Z=Cys+57 Da.)
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GPF matched sequence fragments AAYPG and NLGK. The
peptide sequence was extended to the next tryptic cleavage site
on the left border of AAYPG that de¢nes the sequence
GSGD using the deduced amino acid sequence as a matrix.
However, the mass of the resulting peptide GSGDAAY-
PGNLGK did not match the mass of the precursor ion.
Therefore, the peptide sequence was extended on the right
border of AAYPG and/or left border of NLGK again using
the deduced amino acid sequence as a matrix. Amino acids
are added to prolong the peptide sequence until the mass of
the peptide matches the mass of the precursor ion or exceeds
it, which then terminates the process (Fig. 1, Process 3). In-
sertion of sequence GPFFNLF resulted in peptide GSG-
DAAYPGGPFFNLFNLGK which matches the mass of the
precursor ion and thus de¢nes an intron^exon boundary with-
in the peptide as GSGDAAYPG-intron-GPFFNLFNLGK.
Searching in the Chlamydomonas EST database with this pep-
tide sequence revealed that it can be deduced from the lhca3
gene product [20]. The coding region for this peptide consists
of two exons split by an intron exactly as predicted by
GPF.
We conclude that our approach enables the identi¢cation of
peptides which are split by introns in the genome. In addition,
our approach has the ability to verify and annotate mistakes
in genomic sequences using mass spectrometric data (Process
4, Fig. 1). We suggest that our software tool can be used to
complement Sequest or Mascot search tools when mass spec-
trometric data are used to search in genomic databases to
signi¢cantly increase the number of identi¢ed peptides and
proteins.
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